Australia's Challenger receives takeover bid from Daiichi Life unit
TAL Daiichi Life Australia Pty submitted an indicative proposal to acquire the remaining stake it does not already own in Australian investment manager Challenger for A$11.80 per share, valuing the firm at A$7.94 billion or $5.53 billion, CNA reported. The offer represents a 19.8 per cent premium over the stock's closing price on Friday. The Japanese insurer's unit already holds a 20.36 per cent interest in Challenger, having initially acquired a 15.1 per cent minority stake from MS&AD Insurance Group Holdings in April 2025. Challenger stated that its board is currently considering the indicative offer, which remains subject to conditions including the satisfactory completion of due diligence. Separately, Challenger reported a 5 per cent increase in to $31.9 billion for the first quarter of fiscal 2027, driven by strong sales momentum across domestic and offshore annuities.